Septic Shock Linked to Mortality in Hematologic Malignancies
Mortality rate increases with increasing sequential organ failure assessment score on admission, respiratory failure, maximum lactate level
Prognostic Index May ID CLL Patients Who Will Not Need Treatment
Novel prognostic index CLL-WONT identifies patients with chronic lymphocytic leukemia who are at low risk for ever requiring treatment
Frailty Mars Outcomes After aHSCT in Lymphoid Malignancies
Links found for frailty with in-hospital mortality, prolonged length of stay for patients with NHL, HL, MM undergoing aHSCT
Risk for Cancer Increased After VTE for Patients With Psoriasis
Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years
Pandemic Having Major Impact on Pediatric Oncology Providers
51 percent of institutions cite decreased clinical staff availability; HCPs experiencing psychological distress, financial concerns
Combo Immunotherapy Ups Survival in Advanced Liver Cancer
Overall survival, but not progression-free survival, improved with tremelimumab plus durvalumab versus sorafenib for unresectable HCC
Adding Immunotherapy to Chemo Ups Survival in Advanced Biliary Tract Cancer
Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin
Overall, Night Shift Work Not Tied to Higher Lymphoma Risk
However, nonlinear association seen between night shifts and chronic lymphocytic leukemia
Black Patients More Likely to Have Negative Descriptors in Notes
Compared with White patients, Black patients have 2.54 times the odds of having at least one negative descriptor in EHR
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs
